FDA approves Roche's Avastin for ovarian cancer

Swiss drugmaker Roche said Friday that the Food and Drug Administration approved its drug Avastin as a treatment for ovarian cancer.

Roche said the FDA approved Avastin in combination with chemotherapy as a treatment for recurrent cases of cancer that are resistant to platinum-based chemotherapy.

Avastin is used to treat different types of colon cancer, lung cancer, glioblastoma, kidney cancer and cervical cancer.

Roche reported $6.25 billion in revenue from the drug in 2013.

Explore further

FDA clears Avastin for late-stage cervical cancer

© 2014 The Associated Press. All rights reserved.

Citation: FDA approves Roche's Avastin for ovarian cancer (2014, November 14) retrieved 20 November 2019 from https://medicalxpress.com/news/2014-11-fda-roche-avastin-ovarian-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments